HK1033096A1 - Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculationdisorders - Google Patents
Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculationdisordersInfo
- Publication number
- HK1033096A1 HK1033096A1 HK01103825A HK01103825A HK1033096A1 HK 1033096 A1 HK1033096 A1 HK 1033096A1 HK 01103825 A HK01103825 A HK 01103825A HK 01103825 A HK01103825 A HK 01103825A HK 1033096 A1 HK1033096 A1 HK 1033096A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diuretic
- combination
- converting enzyme
- enzyme inhibitor
- microcirculationdisorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714485A FR2771010B1 (fr) | 1997-11-19 | 1997-11-19 | Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires |
PCT/FR1998/000411 WO1999025374A1 (fr) | 1997-11-19 | 1998-03-03 | Combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1033096A1 true HK1033096A1 (en) | 2001-08-17 |
Family
ID=9513523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01103825A HK1033096A1 (en) | 1997-11-19 | 2001-06-04 | Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculationdisorders |
Country Status (21)
Country | Link |
---|---|
US (1) | US6653336B1 (xx) |
EP (1) | EP1032414B1 (xx) |
JP (1) | JP2001523646A (xx) |
CN (1) | CN1227029C (xx) |
AT (1) | ATE239500T1 (xx) |
AU (1) | AU740748B2 (xx) |
BR (1) | BR9814885A (xx) |
CA (1) | CA2310136C (xx) |
DE (1) | DE69814444T2 (xx) |
DK (1) | DK1032414T3 (xx) |
EA (1) | EA002968B1 (xx) |
ES (1) | ES2198708T3 (xx) |
FR (1) | FR2771010B1 (xx) |
HK (1) | HK1033096A1 (xx) |
HU (1) | HU226022B1 (xx) |
NO (1) | NO20002479D0 (xx) |
NZ (1) | NZ504220A (xx) |
PL (1) | PL340561A1 (xx) |
PT (1) | PT1032414E (xx) |
WO (1) | WO1999025374A1 (xx) |
ZA (1) | ZA986673B (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2811320B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2811319B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2811318B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
US20040156903A1 (en) * | 2002-05-22 | 2004-08-12 | Abrams Andrew L.. | Metering and packaging of controlled release medication |
JP2005514966A (ja) * | 2001-05-31 | 2005-05-26 | マイクロドース・テクノロジーズ・インコーポレーテッド | 放出制御型薬剤の計量およびパッケージング |
FR2841140B1 (fr) * | 2002-06-24 | 2004-10-01 | Servier Lab | Microcapsules pour la liberation retardee et controlee du perindopril |
WO2005021039A1 (en) * | 2003-08-29 | 2005-03-10 | Cotherix, Inc. | Combination of cicletanine and an oral antidiabetic and/or blood lipid-lowering agent for treating diabetes and metabolic syndrome |
CN1292747C (zh) * | 2003-09-16 | 2007-01-03 | 广东省心血管病研究所 | 一种用于治疗高血压的复方制剂 |
DE102004019845A1 (de) * | 2004-03-29 | 2005-10-20 | Krka Tovarna Zdravil D D | Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung |
PL1729739T3 (pl) * | 2004-03-29 | 2017-04-28 | Les Laboratoires Servier | Sposób wytwarzania stałej kompozycji farmaceutycznej |
SI21800A (sl) | 2004-05-14 | 2005-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze perindoprila |
DE102004062257A1 (de) * | 2004-12-23 | 2006-07-06 | Merckle Gmbh | Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung |
MY138209A (en) * | 2005-03-11 | 2009-05-29 | Servier Lab | New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it. |
BRPI0615607A2 (pt) * | 2005-08-30 | 2011-05-24 | Lek Pharmaceuticals | composição farmacêutica compreendendo perindopril ou seus sais |
DE102005058166A1 (de) * | 2005-12-05 | 2007-06-06 | Hexal Ag | Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren |
WO2008068577A2 (en) * | 2006-12-01 | 2008-06-12 | Glenmark Pharmaceuticals Limited | Pharmaceutical compositions |
SI22543A (sl) | 2007-06-27 | 2008-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nove soli perindoprila |
EP2760460B1 (en) * | 2011-09-29 | 2019-11-20 | Mayo Foundation For Medical Education And Research | Aromatic-cationic peptides and methods for using same |
RU2618471C2 (ru) * | 2012-12-03 | 2017-05-03 | Закрытое Акционерное Общество "Вертекс" | Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение |
CA3126333A1 (en) * | 2019-01-09 | 2020-07-16 | Ken-ichi YAMADA | Pharmaceutical composition for intraocular or oral administration for treatment of retinal diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK9200258U4 (da) * | 1992-03-11 | 1993-07-23 | Merck & Co Inc | Farmaceutisk præparat indeholdende enalapril til brug mod hypertension |
ES2193233T3 (es) * | 1995-03-16 | 2003-11-01 | Pfizer | Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica. |
-
1997
- 1997-11-19 FR FR9714485A patent/FR2771010B1/fr not_active Expired - Fee Related
-
1998
- 1998-03-03 JP JP2000520807A patent/JP2001523646A/ja active Pending
- 1998-03-03 DK DK98913813T patent/DK1032414T3/da active
- 1998-03-03 EP EP98913813A patent/EP1032414B1/fr not_active Expired - Lifetime
- 1998-03-03 CN CNB988113163A patent/CN1227029C/zh not_active Expired - Lifetime
- 1998-03-03 EA EA200000536A patent/EA002968B1/ru not_active IP Right Cessation
- 1998-03-03 WO PCT/FR1998/000411 patent/WO1999025374A1/fr active IP Right Grant
- 1998-03-03 NZ NZ504220A patent/NZ504220A/en not_active IP Right Cessation
- 1998-03-03 HU HU0004544A patent/HU226022B1/hu unknown
- 1998-03-03 AU AU68377/98A patent/AU740748B2/en not_active Revoked
- 1998-03-03 US US09/554,715 patent/US6653336B1/en not_active Expired - Lifetime
- 1998-03-03 PT PT98913813T patent/PT1032414E/pt unknown
- 1998-03-03 CA CA002310136A patent/CA2310136C/fr not_active Expired - Lifetime
- 1998-03-03 DE DE69814444T patent/DE69814444T2/de not_active Expired - Lifetime
- 1998-03-03 ES ES98913813T patent/ES2198708T3/es not_active Expired - Lifetime
- 1998-03-03 AT AT98913813T patent/ATE239500T1/de active
- 1998-03-03 BR BR9814885-0A patent/BR9814885A/pt not_active Application Discontinuation
- 1998-03-03 PL PL98340561A patent/PL340561A1/xx unknown
- 1998-07-27 ZA ZA986673A patent/ZA986673B/xx unknown
-
2000
- 2000-05-12 NO NO20002479A patent/NO20002479D0/no not_active Application Discontinuation
-
2001
- 2001-06-04 HK HK01103825A patent/HK1033096A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69814444D1 (de) | 2003-06-12 |
CN1279615A (zh) | 2001-01-10 |
CA2310136A1 (fr) | 1999-05-27 |
NZ504220A (en) | 2003-05-30 |
DE69814444T2 (de) | 2004-03-18 |
JP2001523646A (ja) | 2001-11-27 |
WO1999025374A1 (fr) | 1999-05-27 |
AU6837798A (en) | 1999-06-07 |
EA200000536A1 (ru) | 2000-10-30 |
CA2310136C (fr) | 2004-04-20 |
FR2771010B1 (fr) | 2003-08-15 |
EA002968B1 (ru) | 2002-12-26 |
ES2198708T3 (es) | 2004-02-01 |
HUP0004544A2 (hu) | 2001-06-28 |
PT1032414E (pt) | 2003-08-29 |
BR9814885A (pt) | 2000-10-03 |
ATE239500T1 (de) | 2003-05-15 |
NO20002479L (no) | 2000-05-12 |
EP1032414A1 (fr) | 2000-09-06 |
HUP0004544A3 (en) | 2001-07-30 |
HU226022B1 (en) | 2008-03-28 |
DK1032414T3 (da) | 2003-09-01 |
NO20002479D0 (no) | 2000-05-12 |
US6653336B1 (en) | 2003-11-25 |
PL340561A1 (en) | 2001-02-12 |
AU740748B2 (en) | 2001-11-15 |
ZA986673B (en) | 1999-02-04 |
CN1227029C (zh) | 2005-11-16 |
EP1032414B1 (fr) | 2003-05-07 |
FR2771010A1 (fr) | 1999-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1033096A1 (en) | Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculationdisorders | |
NZ335981A (en) | Ketobenzamides as calpain inhibitors | |
BG102872A (en) | 6-phenylpyridyl-3-amine derivatives | |
BG102425A (en) | (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors | |
AU688952B2 (en) | Thrombin inhibitors | |
ZA981936B (en) | Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase. | |
AP9901674A0 (en) | Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders. | |
IL114015A0 (en) | Inhibitors of interleukin-1beta converting enzyme and pharmaceutical compositions containing the same | |
IL110943A (en) | Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders | |
BG99177A (en) | New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase | |
NZ503308A (en) | Alpha-ketoamide multicatalytic protease inhibitors | |
AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
EP0646007A1 (en) | NEW DELTA-17 AND DELTA-20 UNSATURATED AND SATURATED 17 - g (b) -SUBSTITUTED-4-AZA-5-g (a) -ANDROSTAN-3-ON COMPOUNDS AS INHIBITORS OF 5-ALPHA REDUCTASE. | |
AU8011194A (en) | Compounds, compositions and treatment of allergies and inflammation | |
AU7957894A (en) | Compounds, compositions and treatment of allergies and inflammation therewith | |
BG102814A (en) | New derivatives of carboxylic acid, their preparation and application | |
MX9801190A (es) | Inhibidores de prolil endopeptidasa. | |
EP0858262A4 (en) | THROMBIN INHIBITORS | |
AU7961498A (en) | 9a-azalides, compositions containing such compounds and methods of treatment | |
AU7986098A (en) | 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment | |
ZA9711468B (en) | New use of comt inhibitors | |
HU9601498D0 (en) | Use of dimeticone for treating constipation | |
AU7028798A (en) | Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent | |
BG101526A (en) | Antiphlogistic composition for external application | |
AU8147598A (en) | 8a-azalides, compositions containing such compounds and methods of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20180302 |